Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Lonza Group AG
  6. News
  7. Press Releases
    LONN   CH0013841017

LONZA GROUP AG

(LONN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société LONZA GROUP AG
04:31pHaemaLogiX and Lonza Collaborate to Manufacture KappaMab, a Multiple Myeloma Drug Candi..
PR
01/26LONZA : Full-Year Alternative Performance Measures Report
PU
01/26LONZA : Full-Year Results Report
PU
01/26LONZA : Full-Year Results Presentation
PU
01/26Lonza Delivers Strong 2021 performance with 20% CER Sales Growth
EQ
01/25LONZA : Obtains Order Preventing Infringement of Its Patents Covering the Cocoon® Platform
PU
01/19LONZA : Drug Product Services Participates in the RealHOPE Project to Assess and Improve P..
PU
01/18LONZA : Forbion, and BioGeneration Ventures Extend Collaboration to Add Development and Ma..
PU
01/18LONZA : Launches bYlok Technology for the Discovery and Design of Bispecific Antibodies
PU
2021Lonza and Agilent Announce Strategic Collaboration to Integrate New Analytical Technolo..
AQ
2021LONZA : and Agilent Announce Strategic Collaboration to Integrate New Analytical Technolog..
PU
2021LONZA : Doer Biologics signs licensing agreement with Lonza to develop multi-specific biot..
PU
2021LONZA : and Bioqube Ventures Sign a Framework Agreement for the Future Development and Man..
PU
2021LONZA : and BlueJay Therapeutics Announce Manufacturing Agreement for its Antibody BJT-778..
PU
2021LONZA : to Expand Microbial Development Laboratories
PU
2021Lonza to Acquire Exosomics Service Unit to Expand Exosomes Service Offering
PU
2021LONZA : to Expand Development Services for Mammalian Products in Singapore
PU
2021LONZA : Invests to Expand Drug Product Development and Manufacturing Services in Switzerla..
PU
2021LONZA : Philippe Deecke appointed as Chief Financial Officer of Lonza Group
PU
2021LONZA : and Sheba Medical Center Use Cocoon Platform and Show Successful Clinical Outcomes..
AQ
2021LONZA : and Sheba Medical Center Use Cocoon® Platform and Show Successful Clinical Outcome..
PU
2021LONZA : Half-Year Alternative Performance Measures Report
PU
2021LONZA : Reports Strong Momentum in H1 2021, with 14.7% CER Sales Growth and 33.3% CORE EBI..
PU
2021LONZA : and CN Bio Announce Distribution Agreement Providing Prevalidated Hepatocytes for ..
PU
2021LONZA : Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclo..
PU
2021LONZA : Completes Divestment of Specialty Ingredients Business
AQ
2021LONZA : Completes Divestment of Specialty Ingredients Business
EQ
2021LONZA : Kaged Muscle First to Launch with Lonza's TWK10® Sports Probiotic in the USA
PU
2021LONZA : Restated Financials News Release English
PU
2021GENERAL ANNOUNCEMENT : :Lonza Publishes Restated Financials for 2020
PU
2021LONZA : Publishes Restated Financials for 2020
EQ
2021LONZA : Invests CHF 20 million to Expand API Development and Manufacturing Facility in Nan..
PU
2021LONZA : Pinteon Extends Collaboration with Lonza for Manufacturing PNT001, a Novel Tau Ant..
PU
2021LONZA : CellPoint and Lonza to Leverage the Cocoon Platform for T-Cell Therapeutics Manufa..
PU
2021LONZA : Headline
PU
2021LONZA : SelectImmune Collaborates with Lonza to Develop an Immunotherapeutic Drug Candidat..
PU
2021LONZA : SelectImmune Pharma Collaborates with Lonza to Develop an Immunotherapeutic Drug C..
AQ
2021LONZA : and ValenzaBio Enter Manufacturing Agreement to Rapidly Advance VB421, an anti-IGF..
PU
2021MODERNA : Lonza and Moderna Announce Further Collaboration For Drug Substance Manufacturin..
AQ
2021LONZA : and Moderna Announce Further Collaboration For Drug Substance Manufacturing of COV..
PU
2021LONZA : and Moderna Announce Further Collaboration For Drug Substance Manufacturing of COV..
EQ
2021LONZA : Launches Next Generation 4D-Nucleofector Cell Transfection Platform with Proven Pe..
PU
2021LONZA : Launches Next Gene…nd Enhanced Ease of Use
PU
2021LONZA : Announces Results of the 2021 Annual General Meeting - All Motions Proposed by Boa..
AQ
2021LONZA : Price Change Notification on Selected Product Portfolios
PU
2021LONZA : Announces Results of the 2021 Annual General Meeting – All Motions Proposed ..
PU
2021LONZA : Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities i..
PU
2021LONZA : Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities i..
EQ
2021LONZA : and Ankyra Therapeutics Sign Agreement to Develop and Manufacture a Cytokine Fusio..
PU
2021LONZA : Headline
PU
2021LONZA : and Moderna Enter New Agreement to Double Drug Substance Production for COVID-19 V..
PU
2021LONZA : Announces Construction of a New Small Molecule Manufacturing Complex in Visp
AQ
2021LONZA : Announces Construction of a New Small Molecule Manufacturing Complex in Visp
PU
2021LONZA : Clinically Proven UC-II ® Undenatured Type II Collagen Made with Organic Collagen ..
PU
2021LONZA : and Immunitas Therapeutics Announce Manufacturing Agreement to Rapidly Advance Lea..
PU
2021ATYR PHARMA : and Lonza Announce Manufacturing Agreement for aTyr's Anti-NRP2 Antibody ATY..
AQ
2021LONZA : Expansion of Lonza's Automated Robotic Solution for Endotoxin Testing Automates Su..
AQ
2021LONZA : and Junshi Biosciences Collaborate to Accelerate the Development and Manufacturing..
PU
2021LONZA : Expansion of Lonza's Automated Robotic Solution for Endotoxin Testing Automates Su..
PU
2021LONZA : Specialty Ingredients and Natron Energy Announce Strategic Agreement for Global-Sc..
PU
2021LONZA : Celebrates 20 th Anniversary of Nucleofector™ Cell Transfection Platform
PU
2021LONZA : Completes Divestment of Two Sites to NextPharma
PU
2021LONZA : Pionyr Immunotherapeutics Collaborates with Lonza to Support their Oncology Produc..
PU
2021LONZA : Online Annual Report 2020
PU
2021LONZA : Publishes Invitation to the 2021 Annual General Meeting and 2020 Annual and Sustai..
PU
2021LONZA : LifeClean International and Lonza Specialty Ingredients Sign Distribution Agreemen..
PU
2021LONZA : PsiVac and Lonza Enter a Strategic Agreement for the Process Development and cGMP ..
PU
2021LONZA : is recognised by Ethisphere as One of the World's Most Ethical Companies 2021
AQ
2021LONZA : is recognised by Ethisphere ® as One of the World's Most Ethical Companies 2021
PU
2021LONZA : Expands Solid Form Services for Small Molecule Drugs
PU
2021LONZA : Signs Agreement to Divest Specialty Ingredients Business to Bain Capital and Cinve..
PU
2021LONZA : Announces High-Quality Cryopreserved Leukopaks for More Flexibility in Immunology ..
PU
2021LONZA : Full-Year Results News Release English
PU
2021LONZA : Reports Strong 2020 Performance, Driven By Sales Growth in Pharma and Biotech Busi..
PU
2021LONZA : NextPharma Set to Acquire Two Lonza Sites Specialized in Lipid Oral Dosage Forms
AQ
1  2  3  4  5  6  7  8Next
Upcoming event on LONZA GROUP AG